Pixantrone monotherapy for treating multiply relapsed or refractory aggressive non-Hodgkin's B‑cell lymphoma

Supporting evidence

• Review decision

• Review decision – March 2021

• Review decision paper (PDF 255 KB)

  Published:

  19 March 2021

• Stakeholder list (PDF 141 KB)

  Published:

  19 March 2021

• Review decision – July 2017